Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Federal court blocks Trump DOJ from obtaining transgender youth medical records in California

A federal judge halted the Trump administration's effort to obtain medical records and names of young patients treated at transgender clinics in California. The Department of Justice had sought the files and information about healthcare providers.

06/16/2026 · Wyoming edition

Advertisement

Advertisement

A federal judge in California blocked the Trump administration's attempt to access medical records and identifying information about youth who received care at transgender clinics, at least for now.

The Department of Justice had sought patient files containing names of young people treated at gender-affirming clinics, along with information identifying hospital staff who provided the care. A judge granted a temporary restraining order halting the request, preventing federal authorities from obtaining the records during ongoing litigation.

The ruling came after medical providers and patients challenged the government's demand. Legal advocates said the order protects patient privacy while the case proceeds through the courts.

Details about which specific clinics the DOJ targeted and the scope of the original records request were not immediately clear. The temporary restraining order remains in effect pending further court proceedings.

The case reflects broader tension between the Trump administration's stated policy objectives and existing privacy protections governing medical information. Federal law, including the Health Insurance Portability and Accountability Act, restricts how healthcare providers can share patient data with government agencies.

Transgender healthcare has become a focal point of policy disputes. The administration has previously signaled opposition to gender-affirming medical treatments for minors, though enforcement mechanisms and implementation details have varied across federal agencies.

The judge's action prevents the DOJ from enforcing its records request while the legal challenge moves forward. Attorneys for the clinics and patients argued the government overstepped its authority in demanding the materials.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1102873 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Wyoming

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Wyoming

health

Supreme Court Begins Term with Key Arguments, Denies Hundreds of Cases

The Supreme Court began its new term by hearing arguments in two cases on Monday, focusing on climate change liability and veterans' benefits. The court also denied review in hundreds of cases, including disputes over student speech and COVID-19 vaccine mandates. Future arguments will address retirement fund management and federal environmental laws.

Read Story →
health

Trump Administration Finalizes Healthcare Transparency Rule

The Trump administration has issued a final rule regarding transparency in healthcare coverage. Health and Human Services Secretary Robert F. Kennedy Jr. stated the regulation offers a 'clear view of what healthcare actually costs.' This initiative seeks to increase consumer understanding of medical expenses.

Read Story →
health

GLP-1 Medications See Increased Use, Spur Research into New Applications

GLP-1 medications are now used by an estimated one in eight Americans. Researchers continue to investigate new potential applications for these drugs. The expansion in use prompts further questions and research.

Read Story →
health

Bipartisan Concern Grows Over Pharmacy Benefit Managers

Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.

Read Story →
health

Voters Seek Clear Policy Details, Economic Security from Candidates

Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.

Read Story →
health

Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial

Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.

Read Story →
Scroll for more stories